IL1B and type 2 diabetes mellitus: It has been shown that drugs blocking IL-1β such as IL-1 receptor antagonists (IL-1Ra) or anti-IL-1β antibodies can preserve β-cell function in T2D patients [12,13] and reduce islet inflammation in the type 2 diabetic GK rat [14].